TrialPath
High blood pressure · Denver

High blood pressure clinical trials in Denver

7 recruiting hypertension studies within range of Denver. Click any trial for full eligibility criteria and contact info.

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

NCT06059638 · Hypertension, Hypertension, Systolic, Hypertension, Essential
Recruiting

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

PhaseNA
TypeInterventional
Age18 Years
WhereScottsdale, Arizona, United States + 98 more
SponsorOrchestra BioMed, Inc
Tap for details
Apply

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT04278404 · Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children
Recruiting

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.

Phase
TypeObservational
Age0 Years – 20 Years
WherePhoenix, Arizona, United States + 50 more
SponsorDuke University
Tap for details
Apply

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

NCT06814145 · Hypertension, Pulmonary
Recruiting

Researchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH that is caused by heart failure with preserved ejection fraction (HFpEF). Researchers want to know if the study treatment, sotatercept, can treat people with Cpc-PH caused by HFpEF. This is an extension study, which means people who took part in a certain study on sotatercept for Cpc-PH (called a parent study) may be able to join this study. In this extension study, people will take sotatercept and researchers will follow their health for a longer time. The main goal of this extension study is to learn about the long-term safety of sotatercept and if people tolerate it over a longer period of time.

PhasePhase 2
TypeInterventional
Age18 Years
WherePhoenix, Arizona, United States + 55 more
SponsorMerck Sharp & Dohme LLC
Tap for details
Apply

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

NCT06742723 · Chronic Kidney Disease and Hypertension
Recruiting

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure

PhasePhase 3
TypeInterventional
Age18 Years
WhereFairhope, Alabama, United States + 755 more
SponsorAstraZeneca
Tap for details
Apply

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

NCT06281756 · Insomnia, Insomnia Chronic, Insomnia, Primary
Recruiting

Individuals who have insomnia with short sleep duration (ISS) differ from individuals who have insomnia with normal sleep duration (INS) in terms of health risks (i.e., hypertension) and treatment response. This study will examine whether patients with ISS and INS demonstrate a differential response to two common insomnia treatments. One is behavioral, Cognitive Behavioral Therapy for Insomnia (CBT-I). The other is a widely prescribed, non-habit-forming medication, trazodone used at a low dose. The investigators' findings could lead to evidence-based treatment guidelines that help clinicians more effectively match treatments to insomnia patients and reduce associated health problems.

PhaseEARLY_Phase 1
TypeInterventional
Age18 Years
WhereDenver, Colorado, United States + 3 more
SponsorMilton S. Hershey Medical Center
Tap for details
Apply

Effects of High Altitude on AMPK Activation

NCT02391519 · Pregnancy, IUGR, Preeclampsia
Recruiting

Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high altitude and may contribute to the observed 3-fold increase in intrauterine growth restriction (IUGR) and preeclampsia (PreE). The investigators propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA). If altered MA vasoreactivity is found, further studies may be able to link these changes to the increased rates of PreE and IUGR at altitude and contribute to the understanding of these two disorders.

Phase
TypeObservational
Age18 Years – 45 Years
WhereAurora, Colorado, United States
SponsorUniversity of Colorado, Denver
Tap for details
Apply

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT06388421 · Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Interstitial Lung Disease
Recruiting

This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

Phase
TypeObservational
Age18 Years
WhereBirmingham, Alabama, United States + 60 more
SponsorUnited Therapeutics
Tap for details
Apply